ロード中...
How can we improve the translational landscape for a faster cure of type 1 diabetes?
Translation of novel therapies for type 1 diabetes and other autoimmune diseases to the clinic has been slow despite significant new initiatives from funding agencies. One reason for this is that different incentives drive industry, academia, and funding bodies. These communities therefore lack comm...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2673858/ https://ncbi.nlm.nih.gov/pubmed/19422092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI37593 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|